Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
90.28
-15.06 (-14.30%)
At close: Mar 6, 2026, 4:00 PM EST
90.25
-0.03 (-0.03%)
After-hours: Mar 6, 2026, 7:05 PM EST
Nutex Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Revenue | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 | Upgrade
|
| Revenue Growth (YoY) | 82.36% | 93.80% | 12.93% | -33.85% | 20.98% | Upgrade
|
| Cost of Revenue | 403.95 | 259.12 | 189.78 | 190.74 | 144.59 | Upgrade
|
| Gross Profit | 471.31 | 220.83 | 57.87 | 28.55 | 186.94 | Upgrade
|
| Selling, General & Admin | 58.15 | 47.52 | 38.73 | 19.81 | 5.46 | Upgrade
|
| Operating Expenses | 78.69 | 83.05 | 59.16 | 33.13 | 13.12 | Upgrade
|
| Operating Income | 392.63 | 137.78 | -1.29 | -4.58 | 173.82 | Upgrade
|
| Interest Expense | -22.23 | -19.93 | -16.32 | -12.49 | -6.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -8.62 | -0.94 | -0.4 | -0.56 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | 361.78 | 116.91 | -18.01 | -17.63 | 167.5 | Upgrade
|
| Merger & Restructuring Charges | - | - | -29.34 | -3.89 | -3.55 | Upgrade
|
| Impairment of Goodwill | - | -3.2 | -1.14 | -398.14 | - | Upgrade
|
| Asset Writedown | - | -3.89 | - | - | - | Upgrade
|
| Other Unusual Items | -117 | - | - | - | 5.55 | Upgrade
|
| Pretax Income | 244.78 | 109.83 | -48.49 | -419.65 | 169.49 | Upgrade
|
| Income Tax Expense | 64.42 | 15.02 | -5.07 | 13.09 | 0.97 | Upgrade
|
| Earnings From Continuing Operations | 180.36 | 94.81 | -43.42 | -432.74 | 168.53 | Upgrade
|
| Minority Interest in Earnings | -109.57 | -42.71 | -2.36 | 7.96 | -35.93 | Upgrade
|
| Net Income | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 | Upgrade
|
| Net Income to Common | 70.79 | 52.1 | -45.79 | -424.78 | 132.59 | Upgrade
|
| Net Income Growth | 35.88% | - | - | - | 25.12% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 5 | 4 | 4 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 5 | 4 | 4 | 4 | Upgrade
|
| Shares Change (YoY) | 23.03% | 24.57% | 4.15% | 7.10% | - | Upgrade
|
| EPS (Basic) | 11.13 | 10.23 | -10.39 | -100.36 | 33.55 | Upgrade
|
| EPS (Diluted) | 10.48 | 9.69 | -10.39 | -100.36 | 33.00 | Upgrade
|
| EPS Growth | 8.13% | - | - | - | 23.07% | Upgrade
|
| Free Cash Flow | 241.29 | 20.85 | -8.24 | 35.97 | 136.51 | Upgrade
|
| Free Cash Flow Per Share | 35.71 | 3.80 | -1.87 | 8.50 | 34.54 | Upgrade
|
| Gross Margin | 53.85% | 46.01% | 23.37% | 13.02% | 56.39% | Upgrade
|
| Operating Margin | 44.86% | 28.71% | -0.52% | -2.09% | 52.43% | Upgrade
|
| Profit Margin | 8.09% | 10.85% | -18.49% | -193.70% | 39.99% | Upgrade
|
| Free Cash Flow Margin | 27.57% | 4.34% | -3.33% | 16.41% | 41.17% | Upgrade
|
| EBITDA | 413.16 | 156.76 | 16.3 | 8.55 | 181.48 | Upgrade
|
| EBITDA Margin | 47.20% | 32.66% | 6.58% | 3.90% | 54.74% | Upgrade
|
| D&A For EBITDA | 20.53 | 18.97 | 17.59 | 13.13 | 7.66 | Upgrade
|
| EBIT | 392.63 | 137.78 | -1.29 | -4.58 | 173.82 | Upgrade
|
| EBIT Margin | 44.86% | 28.71% | -0.52% | -2.09% | 52.43% | Upgrade
|
| Effective Tax Rate | 26.32% | 13.68% | - | - | 0.57% | Upgrade
|
| Revenue as Reported | 875.26 | 479.95 | 247.65 | 219.29 | 331.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.